脑部放疗，上午比下午敏感许多！" H1 k3 l. [6 R2 V# a
9 X6 P, l! F6 {) f3 U1 g
! A F: u/ X8 E7 NCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.# M+ s2 t7 @1 e( ^
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?+ P; s7 T/ Y! X( g! i/ R7 p
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
' N- b) t' B6 s# ?7 ^% u2 g# ?' FSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
( F$ K7 l: y. M
, M7 @$ b9 S0 z9 ~9 oAbstract
. l0 x: S3 t& f# EBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
' z' x* H" H8 [& C% U Q$ O$ y5 {0 W! w
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
1 L8 W. e/ y9 v2 e$ P. S" u
5 d" ^6 u7 v. x* h1 aRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
) s4 i! T% F4 H+ s+ c" V# d& M' c1 j0 _" H2 A- p& v% l
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.% n- t) z C2 G0 u% w( N
- x( l# U5 x. z4 ~% Q1 Q* { |
% ~! w' |5 C2 q3 ?; Y/ w4 A7 C
显身卡
